118 related articles for article (PubMed ID: 38458171)
41. Combined QM(DFT)/MM molecular dynamics simulations of the deamination of cytosine by yeast cytosine deaminase (yCD).
Zhang X; Zhao Y; Yan H; Cao Z; Mo Y
J Comput Chem; 2016 May; 37(13):1163-74. PubMed ID: 26813441
[TBL] [Abstract][Full Text] [Related]
42. Host-retrovirus arms race: trimming the budget.
Jern P; Coffin JM
Cell Host Microbe; 2008 Sep; 4(3):196-7. PubMed ID: 18779045
[TBL] [Abstract][Full Text] [Related]
43. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect.
Pierrefite-Carle V; Baqué P; Gavelli A; Mala M; Chazal M; Gugenheim J; Bourgeon A; Milano G; Staccini P; Rossi B
J Natl Cancer Inst; 1999 Dec; 91(23):2014-9. PubMed ID: 10580026
[TBL] [Abstract][Full Text] [Related]
44. A negative selection scheme based on the expression of cytosine deaminase in plastids.
Serino G; Maliga P
Plant J; 1997 Sep; 12(3):697-701. PubMed ID: 9351253
[TBL] [Abstract][Full Text] [Related]
45. Generation and characterization of a human single-chain fragment variable (scFv) antibody against cytosine deaminase from yeast.
Mallano A; Zamboni S; Carpinelli G; Santoro F; Flego M; Ascione A; Gellini M; Tombesi M; Podo F; Cianfriglia M
BMC Biotechnol; 2008 Sep; 8():68. PubMed ID: 18783590
[TBL] [Abstract][Full Text] [Related]
46. A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing.
Grünewald J; Zhou R; Lareau CA; Garcia SP; Iyer S; Miller BR; Langner LM; Hsu JY; Aryee MJ; Joung JK
Nat Biotechnol; 2020 Jul; 38(7):861-864. PubMed ID: 32483364
[TBL] [Abstract][Full Text] [Related]
47. Cytotoxic effects of 5-fluorocytosine on melanoma cells transduced with cytosine deaminase gene.
Lü H; Wu D; Wan Y; Gu B; Wang J
J Environ Pathol Toxicol Oncol; 2000; 19(1-2):9-12. PubMed ID: 10905502
[TBL] [Abstract][Full Text] [Related]
48. Promoter selection for the cytosine deaminase suicide gene constructs in gastric cancer.
Aberle S; Schug N; Mathlouthi R; Seitz G; Küpper JH; Schröder K; Blin N
Eur J Gastroenterol Hepatol; 2004 Jan; 16(1):63-7. PubMed ID: 15095854
[TBL] [Abstract][Full Text] [Related]
49. Recombinant adenoviral vector containing tumor-specific L-plastin promoter fused to cytosine deaminase gene as a transcription unit: generation and functional test.
Chung I; Deisseroth AB
Arch Pharm Res; 2004 Jun; 27(6):633-9. PubMed ID: 15283466
[TBL] [Abstract][Full Text] [Related]
50. Protein-Programmed Accumulation of Yeast Cytosine Deaminase in Cancer Cells in Response to Mock-Hypoxia.
Warren TD; Patel K; Eshleman JR; Ostermeier M
ACS Synth Biol; 2019 May; 8(5):948-954. PubMed ID: 30998310
[TBL] [Abstract][Full Text] [Related]
51. Three-dimensional structure and catalytic mechanism of cytosine deaminase.
Hall RS; Fedorov AA; Xu C; Fedorov EV; Almo SC; Raushel FM
Biochemistry; 2011 Jun; 50(22):5077-85. PubMed ID: 21545144
[TBL] [Abstract][Full Text] [Related]
52. A cytosine deaminase for programmable single-base RNA editing.
Abudayyeh OO; Gootenberg JS; Franklin B; Koob J; Kellner MJ; Ladha A; Joung J; Kirchgatterer P; Cox DBT; Zhang F
Science; 2019 Jul; 365(6451):382-386. PubMed ID: 31296651
[TBL] [Abstract][Full Text] [Related]
53. Redesigned Escherichia coli cytosine deaminase: a new facet of suicide gene therapy.
Raza A; Kohila V; Ghosh SS
J Gene Med; 2015; 17(6-7):132-9. PubMed ID: 25982931
[TBL] [Abstract][Full Text] [Related]
54. A conditional negative selection for Arabidopsis expressing a bacterial cytosine deaminase gene.
Kobayashi T; Hisajima S; Stougaard J; Ichikawa H
Jpn J Genet; 1995 Jun; 70(3):409-22. PubMed ID: 7632443
[TBL] [Abstract][Full Text] [Related]
55. Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.
Albin JS; Brown WL; Harris RS
Virology; 2014 Feb; 450-451():49-54. PubMed ID: 24503066
[TBL] [Abstract][Full Text] [Related]
56. Reaction mechanism of zinc-dependent cytosine deaminase from Escherichia coli: a quantum-chemical study.
Manta B; Raushel FM; Himo F
J Phys Chem B; 2014 May; 118(21):5644-52. PubMed ID: 24833316
[TBL] [Abstract][Full Text] [Related]
57. Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation.
Kobayashi T; Koizumi Y; Takeuchi JS; Misawa N; Kimura Y; Morita S; Aihara K; Koyanagi Y; Iwami S; Sato K
J Virol; 2014 May; 88(10):5881-7. PubMed ID: 24623435
[TBL] [Abstract][Full Text] [Related]
58. APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity.
Swanton C; McGranahan N; Starrett GJ; Harris RS
Cancer Discov; 2015 Jul; 5(7):704-12. PubMed ID: 26091828
[TBL] [Abstract][Full Text] [Related]
59. The cytidine deaminase AID exhibits similar functional properties in yeast and mammals.
Rogozin IB; Pavlov YI
Mol Immunol; 2006 Mar; 43(9):1481-4. PubMed ID: 16219354
[TBL] [Abstract][Full Text] [Related]
60. Markerless Gene Deletion with Cytosine Deaminase in Thermus thermophilus Strain HB27.
Wang L; Hoffmann J; Watzlawick H; Altenbuchner J
Appl Environ Microbiol; 2016 Feb; 82(4):1249-1255. PubMed ID: 26655764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
